Cargando...
Syntheses of FDA Approved HIV Protease Inhibitors
The treatment of HIV and AIDS was revolutionized by the introduction of peptidomimetic aspartyl protease inhibitors. One of the major limitations of this type of therapy is that higher therapeutic doses are necessary because of the presence of ‘peptide-like’ features in the drugs. Therefore, adequat...
Guardado en:
| Publicado en: | Synthesis (Stuttg) |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2001
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6211199/ https://ncbi.nlm.nih.gov/pubmed/30393404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-2001-18434 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|